GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Net Policyholder Benefits/Claims

AngioLab (XKRX:251280) Net Policyholder Benefits/Claims


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


AngioLab (XKRX:251280) Business Description

Industry
Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.